NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 32 filers reported holding NEUROBO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 232,547 | $1,872,000 | 0.38% |
| Hayden Royal, LLC | 22,682 | $182,591,000 | 0.10% |
| Exchange Capital Management, Inc. | 11,145 | $90,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 5,117 | $41,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 106,922 | $861,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,188 | $18,000 | 0.00% |
| NORTHERN TRUST CORP | 78,159 | $629,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 1,768 | $14,000 | 0.00% |
| Legal & General Group Plc | 697 | $6,000 | 0.00% |